APA-viite (7. p.)

van Leeuwen, L., Ruigrok, M., Kessler, B., Leuvenink, H., & Olinga, P. (2023). Targeted delivery of galunisertib using machine perfusion reduces fibrogenesis in an integrated ex vivo renal transplant and fibrogenesis model. Wiley.

Chicago-viite (17. p.)

van Leeuwen, LL, MJR Ruigrok, BM Kessler, HGD Leuvenink, ja P. Olinga. Targeted Delivery of Galunisertib Using Machine Perfusion Reduces Fibrogenesis in an Integrated Ex Vivo Renal Transplant and Fibrogenesis Model. Wiley, 2023.

MLA-viite (9. p.)

van Leeuwen, LL, et al. Targeted Delivery of Galunisertib Using Machine Perfusion Reduces Fibrogenesis in an Integrated Ex Vivo Renal Transplant and Fibrogenesis Model. Wiley, 2023.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.